AtheroGenics, Inc.
(AGIX)
- CAPS Rating:
-
The Company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including coronary heart disease, organ transplant rejection, rheumatoid arthritis and asthma.